368 related articles for article (PubMed ID: 21062462)
21. Downregulation of ATM Gene and Protein Expression in Canine Mammary Tumors.
Raposo-Ferreira TM; Bueno RC; Terra EM; Avante ML; Tinucci-Costa M; Carvalho M; Cassali GD; Linde SD; Rogatto SR; Laufer-Amorim R
Vet Pathol; 2016 Nov; 53(6):1154-1159. PubMed ID: 27106737
[TBL] [Abstract][Full Text] [Related]
22. Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.
Lutful Kabir FM; DeInnocentes P; Bird AC; Bird RC
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):519-530. PubMed ID: 34014456
[TBL] [Abstract][Full Text] [Related]
23. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
24. Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.
Delgado L; Gärtner F; Dias Pereira P
J Comp Pathol; 2015; 152(2-3):138-44. PubMed ID: 25670666
[TBL] [Abstract][Full Text] [Related]
25. Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor.
Park HM; Kim H; Kim DW; Yoon JH; Kim BG; Cho JY
BMB Rep; 2020 Dec; 53(12):664-669. PubMed ID: 33298249
[TBL] [Abstract][Full Text] [Related]
26. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.
Hao X; Sun B; Hu L; Lähdesmäki H; Dunmire V; Feng Y; Zhang SW; Wang H; Wu C; Wang H; Fuller GN; Symmans WF; Shmulevich I; Zhang W
Cancer; 2004 Mar; 100(6):1110-22. PubMed ID: 15022276
[TBL] [Abstract][Full Text] [Related]
27. Next-generation RNA sequencing of FFPE subsections reveals highly conserved stromal reprogramming between canine and human mammary carcinoma.
Amini P; Nassiri S; Ettlin J; Malbon A; Markkanen E
Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31308057
[TBL] [Abstract][Full Text] [Related]
28. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
29. Genomic pathways modulated by Twist in breast cancer.
Vesuna F; Bergman Y; Raman V
BMC Cancer; 2017 Jan; 17(1):52. PubMed ID: 28086829
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
31. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.
Rao NA; van Wolferen ME; Gracanin A; Bhatti SF; Krol M; Holstege FC; Mol JA
J Physiol Pharmacol; 2009 May; 60 Suppl 1():73-84. PubMed ID: 19609016
[TBL] [Abstract][Full Text] [Related]
33. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
34. Metastasis prognostic factors and cancer stem cell-related transcription factors associated with metastasis induction in canine metastatic mammary gland tumors.
Kim S; Bok E; Lee S; Lee HJ; Choe Y; Kim NH; Lee WJ; Rho GJ; Lee SL
J Vet Sci; 2021 Sep; 22(5):e62. PubMed ID: 34423600
[TBL] [Abstract][Full Text] [Related]
35. SFRP1 Expression is Inversely Associated With Metastasis Formation in Canine Mammary Tumours.
Seitz J; Bilsland A; Puget C; Baasner I; Klopfleisch R; Stein T
J Mammary Gland Biol Neoplasia; 2023 Jul; 28(1):15. PubMed ID: 37402051
[TBL] [Abstract][Full Text] [Related]
36. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
[TBL] [Abstract][Full Text] [Related]
37. Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?
Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD; Klopfleisch R
J Proteome Res; 2011 Oct; 10(10):4405-15. PubMed ID: 21888431
[TBL] [Abstract][Full Text] [Related]
38. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors.
Bergholtz H; Lien T; Lingaas F; Sørlie T
J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):171-183. PubMed ID: 35932380
[TBL] [Abstract][Full Text] [Related]
40. Identification of prognostic collagen signatures and potential therapeutic stromal targets in canine mammary gland carcinoma.
Case A; Brisson BK; Durham AC; Rosen S; Monslow J; Buza E; Salah P; Gillem J; Ruthel G; Veluvolu S; Kristiansen V; Puré E; Brown DC; Sørenmo KU; Volk SW
PLoS One; 2017; 12(7):e0180448. PubMed ID: 28683102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
